Results 321 to 330 of about 236,526 (353)

Correction: The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and hepatic steatosis and liver fibrosis among US adults based on NHANES. [PDF]

Sci Rep
Li B, Liu Y, Ma X, Guo X.
europepmc   +1 more source

Diet and Lifestyle Interventions in Metabolic Dysfunction-Associated Fatty Liver Disease: A Comprehensive Review. [PDF]

Int J Mol Sci
Sheikh MY, Younus MF, Shergill A, Hasan MN.   +3 more
europepmc   +1 more source

Metabolic factors moderate the association between hepatic fibrosis and atherosclerotic cardiovascular risk in type 2 diabetes. [PDF]

BMJ Open Diabetes Res Care
Lu L, Gao C, Wu N, He S, Liu Y, Zhang N, Zhou J.   +6 more
europepmc   +1 more source

White adipose tissue browning and peroxisome proliferator activated receptors in MASLD. [PDF]

Front Endocrinol (Lausanne)
Li Z, Chu H, Yang L.
europepmc   +1 more source

Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis

Nature Biotechnology, 2023
The lack of registered drugs for nonalcoholic fatty liver disease (NAFLD) is partly due to the paucity of human-relevant models for target discovery and compound screening.
Delilah F G Hendriks, Jos F Brouwers
exaly   +2 more sources

Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women

Nature Medicine, 2018
Hepatic steatosis is a multifactorial condition that is often observed in obese patients and is a prelude to non-alcoholic fatty liver disease. Here, we combine shotgun sequencing of fecal metagenomes with molecular phenomics (hepatic transcriptome and ...
L Hoyles, Massimo Federici, Matteo Serino   +2 more
exaly   +2 more sources

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology, 2019
BACKGROUND & AIMS We estimated the accuracy of FibroScan vibration-controlled transient elastography controlled attenuation parameter (CAP) and liver stiffness measurement (LSMs) in assessing steatosis and fibrosis in patients with suspected nonalcoholic
Peter Eddowes, Magali Sasso, Michael Allison   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

Hepatology, 2004
Jay D Horton, Scott M Grundy, Helen H Hobbs   +2 more
exaly   +2 more sources

Cellular senescence drives age-dependent hepatic steatosis

Nature Communications, 2017
The incidence of non-alcoholic fatty liver disease (NAFLD) increases with age. Cellular senescence refers to a state of irreversible cell-cycle arrest combined with the secretion of proinflammatory cytokines and mitochondrial dysfunction. Senescent cells
Mikolaj Ogrodnik, Satomi Miwa, Tamar Tchkonia   +2 more
exaly   +2 more sources

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography

Gastroenterology, 2016
BACKGROUND & AIMS Noninvasive methods have been evaluated for the assessment of liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease (NAFLD).
Kento Imajo, Takaomi Kessoku, Yasushi Honda   +2 more
exaly   +2 more sources